exemestane sandoz
sandoz pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: mannitol; polysorbate 80; microcrystalline cellulose; hypromellose; macrogol 400; colloidal anhydrous silica; titanium dioxide; magnesium stearate; sodium starch glycollate type a; crospovidone - exemestane sandoz is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy.,exemestane sandoz is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.
exemestane 25mg tablets
beacon pharmaceuticals ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
teva uk ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
pfizer ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
zentiva pharma uk ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
alliance healthcare (distribution) ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
a a h pharmaceuticals ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
actavis uk ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
accord-uk ltd - exemestane - oral tablet - 25mg
exemestane 25mg tablets
sigma pharmaceuticals plc - exemestane - oral tablet - 25mg